Showing 1 - 20 results of 110 for search '"cannabinoid"', query time: 0.05s Refine Results
  1. 1

    Cannabinoid Hyperemesis by Stephen Sullivan

    Published 2010-01-01
    “…Cannabinoid hyperemesis syndrome is characterized by chronic, heavy use of cannabis, recurrent episodes of severe nausea and intractable vomiting, and abdominal pain. …”
    Get full text
    Article
  2. 2
  3. 3
  4. 4

    Guidelines for the Use of Cannabinoid Compounds in Chronic Pain by AJ Clark, ME Lynch, M Ware, P Beaulieu, IJ McGilveray, D Gourlay

    Published 2005-01-01
    “…OBJECTIVE: To provide clinicians with guidelines for the use of cannabinoid compounds in the treatment of chronic pain.…”
    Get full text
    Article
  5. 5
  6. 6

    Cannabinoids: A New Group of Agonists of PPARs by Yan Sun, Andy Bennett

    Published 2007-01-01
    “…Cannabinoids have been used medicinally and recreationally for thousands of years and their effects were proposed to occur mainly via activation of the G-protein-coupled receptor CB1/CB2 (cannabinoid receptor 1/2). …”
    Get full text
    Article
  7. 7

    Preclinical Science Regarding Cannabinoids as Analgesics: An Overview by ME Lynch

    Published 2005-01-01
    “…Since then, potent antinociceptive and antihyperalgesic effects of cannabinoid agonists in animal models of acute and chronic pain; the presence of cannabinoid receptors in pain-processing areas of the brain, spinal cord and periphery; and evidence supporting endogenous modulation of pain systems by cannabinoids has provided support that cannabinoids exhibit significant potential as analgesics. …”
    Get full text
    Article
  8. 8
  9. 9

    The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity by Jose Orsini, Christa Blaak, Eric Tam, Salil Rajayer, Joaquin Morante, Angela Yeh, Ashvin Butala

    Published 2015-01-01
    “…Even though synthetic cannabinoids have been restricted, they are still readily available across USA and their use has been dramatically increasing, with a concomitant increment in reports to poison control centers and emergency department (ED) visits. …”
    Get full text
    Article
  10. 10
  11. 11
  12. 12

    Safety Issues Concerning the Medical Use of Cannabis and Cannabinoids by Mark A Ware, Vivianne L Tawfik

    Published 2005-01-01
    “…Standardized, quality-controlled cannabinoid products are available in Canada, and safety profiles of approved medications are available through the Canadian formulary. …”
    Get full text
    Article
  13. 13

    Brugada Phenocopy Type 1 Secondary to Synthetic Cannabinoids by Mohammad Amro, Kelechukwu U. Okoro, Kanaan Mansoor, Ahmed Amro, Paul Okhumale

    Published 2020-01-01
    “…We present a very rare case of a young patient who had a Brugada phenocopy Type 1 suspected to be secondary to synthetic cannabinoids.…”
    Get full text
    Article
  14. 14

    Update on the Role of Cannabinoid Receptors after Ischemic Stroke by Luciano S. A. Capettini, Silvia Q. Savergnini, Rafaela F. da Silva, Nikos Stergiopulos, Robson A. S. Santos, François Mach, Fabrizio Montecucco

    Published 2012-01-01
    “…Cannabinoids are considered as key mediators in the pathophysiology of inflammatory diseases, including atherosclerosis. …”
    Get full text
    Article
  15. 15

    Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials by Mark Ware, Pierre Beaulieu

    Published 2005-01-01
    “…Over the past five years, there has been a considerable increase in clinical research on cannabinoid use for a range of pain syndromes. Cannabinoid products are becoming available for research and clinical use, and pharmaceutical industry interest in the potential for cannabinoids in therapeutics is also gaining momentum. …”
    Get full text
    Article
  16. 16
  17. 17

    Muscarinic cannabinoid suppression of excitation, a novel form of coincidence detection by Michaela Dvorakova, Ken Mackie, Alex Straiker

    Published 2025-02-01
    “…We refer to this inhibition as muscarinic cannabinoid suppression of excitation (MCSE). MCSE can be mimicked by coapplication of muscarinic and cannabinoid agonists and requires Ca2+-release from internal stores. …”
    Get full text
    Article
  18. 18

    A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria by Osamah Hasan, Ankit A. Patel, James J. Siegert

    Published 2019-01-01
    “…Recreational use of synthetic cannabinoids (SCs), also known as “K2” or “Spice,” is becoming a major public-health concern due to their potential for abuse and harmful consequences. …”
    Get full text
    Article
  19. 19
  20. 20